New Comprehensive Phase 3 Data Show First-in-Class TREMFYA&#

New Comprehensive Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced comprehensive efficacy and safety data from the DISCOVER–2 trial of...

Related Keywords

Langley , British Columbia , Canada , Japan , Spring House , United States , Horsham , Saskatchewan , American , Jennifer Mcintyre , Alyssa Johnsen , Donvitot Creakyjoints , Philip Mease , Bridget Kimmel , Zismand Comorbidities , Item Short Form Survey Physical Component Summary , American College Of Rheumatology , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , University Of Washington School Medicine , National Psoriasis Foundation , Swedish Medical Center Providence St , Journal Of The American Academy Dermatology , None Of The Janssen Pharmaceutical Companies , Stanford Health Assessment Questionnaire , Joseph Health , Drug Administration , Health Assessment Questionnaire Disability Index , Arthritis Research Therapy , Exchange Commission , Companies Of Johnson , Group For Research , Rheumatology Research , Johnson , American College , Global Assessment , Swedish Medical , Clinical Professor , Washington School , Heijde Modified Sharp , Vice President , Rheumatology Disease Area Leader , Janssen Research , Psoriasis Area , Severity Index , Psoriatic Arthritis , Mental Component Score , Prescribing Information , Medication Guidefor , Pharmaceutical Companies , Infectious Diseases , Private Securities Litigation Reform Act , Annual Report , Note Regarding Forward Looking , Quarterly Report , Monoclonal Antibody Specific , Placebo Controlled Study Conducted , Active Psoriatic , Specific Monoclonal Antibody , Through One Year , Naive Patients With Psoriatic , Safety Results Through One Year , American Academy , Safety Results Of Two , Participants With Active Psoriatic Arthritis , Accessed October , Gone Prior , Guselkumab Administered Subcutaneously , Dermatological Treatment , Accessed Oct , Rheum Dis , Painful Arthritis Symptom You Should Know , Sausage Finger Swelling You Should Know , Rambam Maimonides Med , About Psoriatic , Immune Based Therapies , Study Evaluating , Janssen Pharmaceutical Companies Of Johnson Amp , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,

© 2025 Vimarsana